Immunocore Holdings PLC
(STU:6YG)
€
33.2
-1 (-2.94%)
Market Cap: 1.65 Bil
Enterprise Value: 1.23 Bil
PE Ratio: 0
PB Ratio: 3.93
GF Score: 81/100 Immunocore Holdings PLC (STU:6YG) Transcripts
- Q4 2023 Immunocore Holdings PLC Earnings Call TranscriptFeb 28, 2024€64 (-0.78%)Earnings
- Immunocore Holdings PLC at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Immunocore Holdings PLC at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Immunocore Holdings PLC Earnings Call TranscriptAug 10, 2023€56 (-0.88%)Earnings
- Immunocore Holdings PLC at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Immunocore Holdings PLC at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Immunocore Holdings PLC at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 Immunocore Holdings PLC Earnings Call TranscriptMar 01, 2023€50.5 (-1.94%)Earnings
- Immunocore Holdings PLC at Citi Virtual Oncology Leadership Summit TranscriptFeb 22, 2023
- Immunocore Holdings PLC at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Immunocore Holdings PLC at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 30, 2022
- Immunocore Holdings PLC at Jefferies London Healthcare Conference TranscriptNov 17, 2022
- Immunocore Holdings PLC PRAME Investor and Analyst Event AT ESMO 2022 TranscriptSep 09, 2022
- Q2 2022 Immunocore Holdings PLC Earnings Call TranscriptAug 10, 2022€49.8 (-3.30%)Earnings
- Immunocore Holdings PLC at Needham Healthcare Conference (Virtual) TranscriptApr 14, 2022
- Immunocore Holdings PLC To Discuss FDA Approval Call TranscriptJan 26, 2022
- 1